PDS Biotechnology (PDSB) 10-K2020 FY Annual report

Filed: 18 Mar 21, 5:30pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: Addavax, Aid, alfa, Anderson, Anvisa, awaiting, banker, Biden, biggest, Bintrafusp, biochemical, Blanver, Bloomberg, Brawley, Brazilian, bulleted, camouflage, cascade, chemoradiotherapy, coated, confronting, consortium, convergence, correspondingly, costimulatory, CPRA, CRT, cyber, cyberattack, cybersecurity, daunting, deployment, destroy, destruction, domestic, Epidemiology, epithelial, eradicate, eradicated, eradication, evade, exciting, fatty, float, flu, Gandhapudi, Genocea, Gritstone, guide, hampered, Harpoon, Heat, hidden, highlight, highlighted, Hookipa, Hubei, hydrocarbon, hydrolyzed, Icahn, immunogenic, immunogenicity, Immunomodulation, inactivated, Indenture, influenza, insoluble, Interestingly, John, landscape, learning, legislature, MCTI, mechanistic, messenger, microscopic, migrate, Ministry, modulate, Mount, mounting, MTA, Nacional, NDV, network, neutralizing, Newcastle, OncoSec, ORR, overexpressed, pace, page, pathogenic, penetration, pervasive, Pharm, proactive, problematic, prompted, Province, PSA, quarantine, rationale, recur, refractory, refund, reinjected, remote, Republic, risky, Rumfield, Seth, Sinai, sophisticated, sparing, Spike, subunit, swelling, tail, task, telemedical, theft, TME, transient, triple, undertook, undetected, uneconomical, unfold, vaginal, Van, versality, vigilance, vigilant, wrought, ZIOPHARM

Removed: accelerated, accruing, Alyssa, amortized, Andrew, Auxilium, Bradford, Brian, channel, circumvented, collected, collusion, coupled, death, delaying, demonstration, detailed, developmental, dramatic, eligible, equivalent, escalating, expended, expired, Faleck, faulty, favor, furnished, golden, Herbert, holding, influencing, inhibit, irrevocably, Kingdom, lender, Leuthner, load, Maxim, measured, Middlekauff, mistake, modified, move, negotiated, nonbinding, nonqualified, Oakwood, organizational, originally, override, parachute, particulate, prevented, recruitment, represent, resolved, revised, Saik, Schema, surgery, telephone, turn, unbilled, validate, Wyant

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated PDSB transcripts

PDSB similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

PDS Biotechnology Corporation:

We consent to the incorporation by reference in the registration statement (No. 333-240011) on Form S-3 and in the registration statements (No. 333-234693, No. 333-231945, No. 333-231943, No. 333-229817, No. 333-223390, 333-2223389, No. 333-216431, No. 333-216430, No 333-210042, No.333-210041, and No. 333-207545) on Form S-8 of PDS Biotechnology Corporation of our report dated March 18, 2021, with respect to the consolidated balance sheets of PDS Biotechnology Corporation as of December 31, 2020 and 2019, the related consolidated statements of operations and comprehensive loss, changes in stockholders’ equity (deficit), and cash flows for the years then ended December 31, 2020, and the related notes, which report appears in the December 31, 2020 annual report on Form 10-K of PDS Biotechnology Corporation.

Short Hills, New Jersey

March 18, 2020